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358a Monday, February 27, 2012in myofilament Ca2þ sensitivity was abolished by the expression of b-Tm. Fur-
thermore, the McTnT 45-74 deletion-induced reduction in cooperativity of
force production was more pronounced under a b-Tm background. Thus, our
data shows that changes in the isoform expression of Tm modify T1-
dependent cardiac function, indicating that T1-Tm interactions exert a modula-
tory role in regulating cardiac thin filament activation.
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In the heart, stimulation of b-adrenergic pathway and subsequent activation
of protein kinase A (PKA) is known to increase myocardial contractility. The
increase in contractility is, in part, due to target phosphorylation of troponin
I (TnI). In this study, we sought to identify novel target sites for PKA that
could potentially contribute to this increase in contractility. To induce phos-
phorylation of TnI, cardiac and fast skeletal muscle from 3-4 month old
Sprague Dawley rats was mechanically disrupted and demembranated fol-
lowed by incubation with the catalytic subunit of PKA (50U PKA/ 3mg tis-
sue , 0-30 min). To identify target specific phosphorylation on fast skeletal
(fsTnI) or cardiac (cTnI) TnI, western blot analysis with phospho-specific
antibodies was performed. PKA treatment increased phosphorylation of
cTnI at ser22/23, as expected, but also at ser149. Similarly, PKA treatment
increased phosphorylation of fsTnI at ser117, which is the equivalent to
ser149 in cTnI. Accordingly, fsTnI demonstrated no observable phosphory-
lation at ser22/23. Adenosine-monophosphate activated kinase (AMPK) has
been shown to target ser149 of cTnI. Therefore, to validate PKA-
dependent phosphorylation of cTnI at ser149, hearts were excised and per-
fused with AICAR, a known activator of AMPK. AICAR-perfused hearts
demonstrated a time-dependent increase in phosphorylation of cTnI at
ser149. These results demonstrate that PKA-dependent phosphorylation can
target ser149 in cTnI and, equivalently, ser117 in fsTnI. The functional con-
sequence of this target site phosphorylation and how it impacts contractility
is currently under investigation.
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Dilated Cardiomyopathy (DCM) and Familial Hypertrophic Cardiomyopathy
(FHC) are pathological heart conditions mainly associated with sarcomeric
mutations that lead to contractile dysfunction. Despite the identification of
several mutations associated with FHC and DCM, the role of these mutations
in pathological cardiac-remodeling is still elusive. Therefore, we studied
length-dependent contractile parameters of murine hearts expressing DCM-
associated mutation (D230N in alpha-tropomyosin) and FHC-associated
mutation (R92L in cTnT). Mechanical studies were carried out on
detergent-skinned cardiac muscle fibers at sarcomere length (SL) 1.9 and
2.3 mm. Our preliminary results show that myofilament Ca2þ sensitivity and
cooperativity are affected differently in both mutants, irrespective of SL.
Ca2þ sensitivity was decreased in the D230N fibers, but increased in R92L fi-
bers. Ca2þ-activated maximal tension was unaltered in both examples. Coop-
erativity of myofilament activation was significantly decreased in R92L fibers
and significantly increased in D230N fibers. Our results suggest that single
amino acid substitution mutations in Tm (D230N) and TnT (R92L) cause di-
verse functional effects, which may correlate with varied pathological remod-
eling. Further mechano-dynamic studies are planned to determine if other
aspects of myofilament activation may be involved in the evolution of compli-
cations associated with DCM and FHC.
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The FHC-related cTnC mutation, L29Q, is located at the dysfunctional bind-
ing site I of cTnC and interacts with the N-terminus of cardiac troponin I
(cTnI) during muscle contraction. Recent studies suggest that the L29Q
cTnC mutation affects Ca2þ activation and the transduction of PKA-dependent phosphorylation (S23/24) cTnI effect on cTnC, but the results
are contradictory. Therefore, to investigate whether the L29Q cTnC mutation
abrogates the effects of PKA-dependent phosphorylation of cTnI of the
Ca2þ sensitivity of cTnC, we examined the Ca2þ binding properties in mul-
tiple biochemical systems of increasing complexity. Mouse cTn was recon-
stituted with phosphomimetic cTnI (S23/24D), cTnT, and IAANS-labeled
control TnC (T53C, C84S, C35S) 5 the L29Q mutation. Steady-state
Ca2þ binding and Ca2þ dissociation rates were measured in the isolated
cTn as well as the reconstituted thin filaments. There was no significant dif-
ference between steady-state Ca binding for the control cTn (0.9850.07mM)
and L29Q cTn (0.9950.08mM), nor a difference in the Ca2þ dissociation
kinetics of reconstituted thin filaments, control (300510/s) and L29Q
(280510/s). However, L29Q cTnC in skinned cardiac myocytes increased
Ca sensitivity by 1.2 fold and reduced the decrease in Ca2þ sensitivity
caused by phosphomimetic cTnI by ~ 45%, as well as the enhanced length
dependent Ca2þ sensitivity. These results suggest that the Ca2þ association
rate, rather than the dissociation rate was affected by L29Q in the reconsti-
tuted thin filament. In conclusion, the cTnC L29Q mutation increased Ca2þ
sensitivity of force generation and exacerbated the functional effects of TnI
phosphorylation at S23/24 in skinned cardiac myocytes, but did not alter
changes in the Ca2þ dissociation rate in the reconstituted thin filament
caused by phosphomimetic cTnI.
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Doxorubicin (adriamycin) is an effective anti-cancer drug, but its clinical us-
age is limited by a dose-dependent cardiotoxicity characterized by widespread
sarcomere disarray and loss of myofilaments. Cardiac ankyrin repeat protein
(CARP, ANKRD1) is a transcriptional regulatory protein that is extremely
susceptible to doxorubicin, however, the mechanism(s) of doxorubicin-
induced CARP suppression and its specific role in cardiomyocyte biology re-
mains to be elucidated. In this study, we report that treatment of cardiomyo-
cytes with doxorubicin resulted in complete suppression of CARP promoter
activity, decreased CARP protein levels, and marked sarcomere disarray.
Transfection of CARP siRNA in cardiomyocytes resulted in a complete de-
pletion of CARP and significant disruption of sarcomere ultrastructure.
Adenoviral overexpression of CARP, however, was unable to rescue the
doxorubicin-induced sarcomere disarray phenotype. GATA4 has previously
been shown to regulate CARP, thus we examined the role of GATA4 in
doxorubicin-induced CARP depletion. Cardiomyocytes treated with doxorubi-
cin show a concomitant depletion of CARP and GATA4 protein levels.
GATA4 siRNA inhibits while GATA4 overexpression enhances CARP pro-
moter activity in cardiomyocytes. Both GATA4 and CARP siRNA signifi-
cantly repressed titin and actin promoter activity. These data show that in
cardiomyocytes transcription factor GATA4 is upstream of CARP and that
doxorubicin induces a rapid down-regulation of GATA4 resulting in inhibi-
tion of CARP transcription. Our data further support a role for a GATA4/
CARP signaling axis in sarcomere maintenance and that suppression of this
pathway contributes, in part, to the overall pathophysiology of doxorubicin
cardiomyopathy.
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We are interested in the mechanism of phosphorylation of smooth muscle my-
osin (SMM) by the myosin light chain kinase -calmodulin-Ca2þ complex
(MLCK-CaM-Ca2þ). This reaction is required for activation of SMM catalytic
activity and smooth muscle contraction. In previous studies we characterized
tightly-bound SMM-MLCK-CaM complexes in an in vitro model system and
demonstrated that SMM-MLCK-CaM complexes co-purified from smooth
muscle were functional, i.e. MLCK was able to phosphorylate SMM and the
phosphorylated SMM resulted in actin filament motility in an in vitro assay.
Moreover, using total internal reflectance fluorescence microscopy (TIRF),
we observed dynamic interactions between single MLCK and SMM molecules
by visualizing quantum dot-labeled MLCK (QD-MLCK) interacting with
SMM aligned on actin filaments.We have also observed that QDs-MLCK
moved along the pure actin filaments. We are currently using cultured human
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mine the mechanism whereby one MLCK phosphorylates many SMM mole-
cules. Direct observations of single QD-labeled MLCK molecules show
clearly that MLCK co-localizes with and can move along the actin- and
myosin-containing stress fibers, under the conditions of high ionic strength,
or physiological ionic strength with CaM-Ca2þ and ATP. The diffusion
coefficient, calculated from mean-squared-displacement (MSD) data from
MLCK-QDs’ trajectories, indicates that the mechanism by which one MLCK
phosphorylates multiple SMMs may involve MLCK movement along thick
and/or thin filaments on a time scale measured in seconds.
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Telokin is a smooth muscle (SM)-specific protein identical to the C-terminal
domain of myosin light chain kinase (MLCK). Telokin retards myosin phos-
phorylation and accelerates its dephosphorylation, but not by simple competi-
tion with MLCK. Telokin also prevents myosin’s folded conformation. This
study explores the effect of telokin on the mechanics of thiophosphorylated
SM myosin. We used the in vitro motility assay which consists in observing
the movement of fluorescently labeled actin filaments as they are propelled
by myosin molecules adhered to a microscope coverslip. Four protocols were
used: 1) telokin and myosin were incubated together before adhering to the cov-
erslip; 2) to ensure myosin adherence to the coverslip, telokin was added after
myosin was adhered; 3) to verify whether telokin affects myosin or actin, telo-
kin was incubated with labeled actin before addition to the myosin adhered on
the coverslip; 4) to assess the effects of telokin on actin polymerization, vor-
texed labeled actin was allowed to repolymerize in the presence of telokin
and was then added to the coverslip. Result-1: telokin led to actin filament
breakage and thus motility was poor. Difference in filament length was used
as a measure of actin breakage. Actin filaments were significantly shorter in
the presence of telokin (3.72mm50.2 vs. 6.32mm50.98, n=4, p<0.05). Result
2: A non-statistically significant trend towards shorter filaments was observed
in the presence of telokin (3.46mm50.57 vs. 4.84mm50.3, n=4, p=0.073). Re-
sult 3: No difference in filament length was observed. Result 4: Actin filaments
were significantly shorter when repolymerized in the presence of telokin
(1.14mm50.16 vs. 2.39mm50.44, n=4, p<0.05). In conclusion, telokin acts
on thiophosphorylated SM myosin, potentially by altering its conformation,
to create strong binding, rigor-like cross-bridges. It also affects actin filament
assembly.
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Phosphorylation of the myosin regulatory light chain (RLC) may be important
for regulating the contraction of vertebrate striated muscle fibers. Mutations af-
fecting phosphorylation of the RLC have been shown to correlate with certain
familial hypertrophic cardiomyopathies (FHCs), most notably the E22K muta-
tion known to prevent serine-15 RLC phosphorylation. We hypothesise that al-
tered RLC phosphorylation affects both the Ca2þ -sensitivity and power output
of permeabilized cardiac trabeculae, myofilaments and single myosin mole-
cules. We exchanged expressed non-phosphorylated Rhodamine-labeled car-
diac RLC into permeabilized cardiac trabeculae from rat. Temperature jump
(T-jump) activation and force-velocity measurements were used to observe
changes to mechanical properties of trabeculae. Phos-tagTM SDS-PAGE anal-
ysis of left ventricular homogenate from Sprague-Dawley rats determined en-
dogenous RLC phosphorylation levels of 0.44 mol of Pi per mol of RLC.
Preliminary force-velocity results using T-jump activation at 20oC of control
permeabilized left ventricular cardiac trabeculae (n=5) indicated a peak short-
ening velocity of 7.95 0.1 FL/s, the shortening velocity at peak power output
as 1.8 5 0.1 FL/s, at which peak isotonic force was measured to be 16.9 5
1.5% of peak isometric force, 1005 9 kN/m2. We propose to alter phosphor-
ylation of recombinant RLC in-vitro and exchange with native trabecular RLC
to see the effects of changing RLC phosphorylation on contractile parameters
such as peak power, Vmax and pCa50.1821-Pos Board B591
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An increase in vascular stiffness is a fundamental component of hypertension.
Our hypothesis is that the increased large artery stiffness in hypertension is due
in part to intrinsic properties of vascular smooth muscle cells (VSMCs). Adult
spontaneously hypertensive rats (SHR) (16 weeks old) and age-matched
Wistar-Kyoto normotensive (WKY) rats were studied. Aortic pressure,
measured with a Millar catheter, was higher in SHR than WKY (mean arterial
pressure 12354 vs. 9656 mmHg). Aortic stiffness, measured with Doppler
imaging echocardiography, in vivo, was 2 to 2.5 fold higher, p<0.05, in hyper-
tensive rats compared to normotensive rats. Aortic tissue rings and VSMCs
were isolated from the SHR and WKY rats and VSMC stiffness was measured,
in vitro, in both a reconstituted tissue model and with atomic force microscopy
(AFM) in single VSMC’s. The continuous force curves with the AFM in single
VSMCs were collected and the temporal variation in VSMC elasticity was
evaluated by Eigen decompensation. VSMC stiffness was consistently in-
creased by 1.5 to 2 fold in SHR vs. WKY (p<0.05). Moreover, the oscillations
in elasticity were significantly different between the two groups in terms of fre-
quency and amplitude (p<0.05). These observations suggest that not only in-
herently altered VSMC stiffness, but also unique dynamic elements, are
involved in the mechanism of increased aortic stiffness in hypertensive rats.
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In these experiments, a spectral analysis approach was developed for detailed
study of time resolved, dynamic changes in vascular smooth muscle cell
(VSMC) elasticity and adhesion. Atomic force microscopy (AFM) was used
to continuously measure Young’s modulus of elasticity and adhesion as as-
sessed by fibronectin or anti-beta 1 integrin interaction with the VSMC surface.
Measurements demonstrated that VSMC cells from old versus young monkeys
had elevated elasticity (21.6 kPa vs. 3.5 kPa or a 612% elevation in elastic mod-
ulus) and adhesion (86 pN vs. 43 pN or a 200% increase in unbinding force).
Spectral analysis identified three major frequency components in the temporal
oscillation patterns for elasticity (ranging from 1.7x10-3 to 1.9x10-2 Hz in old
and 8.4x10-4 to 1.5x10-2 in young) and showed that the amplitude of oscilla-
tion was significantly (p<0.05) larger in old than in young at all frequencies. It
was also observed that patterns of oscillation in the adhesion data were similar
to those seen in the elasticity waveforms. In conclusion, these data demonstrate
that time resolved analysis of AFM cell elasticity and adhesion measurements
provides a uniquely sensitive method to detect functional differences in me-
chanical and adhesive properties of cells. Aging was observed to increase
both elasticity and adhesion in VSMC and also to increase the amplitude and
frequency of certain oscillatory components.
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The I-band portion of the giant muscle-protein titin is elastic but detailed
knowledge of titin arrangement and interactions in this region is lacking.
We determined whether or not select domains from this region can
associate with one another, as observed for titin’s ‘‘distal’’ immunoglobulin
